Our goal is to find innovative therapies that address significant unmet medical needs for patients with inflammatory, rare and specialty diseases, and cancer

Experienced management team with more than 50 plus years of industry experience in small molecules, antibodies, and antibody-drug-conjugates (ADC) drug development and has successfully forged companies that create best-in-class therapeutics during their tenures.